THIRD-PARTY TESTED · COA AVAILABLE◆FREE U.S. SHIPPING ON ORDERS $200+◆SHIPS IN 24–48 BUSINESS HOURS◆DISCREET, PROTECTIVE PACKAGING◆RESEARCH USE ONLY◆THIRD-PARTY TESTED · COA AVAILABLE◆FREE U.S. SHIPPING ON ORDERS $200+◆SHIPS IN 24–48 BUSINESS HOURS◆DISCREET, PROTECTIVE PACKAGING◆RESEARCH USE ONLY◆
Tirzepatide 10mg lyophilized research peptide, a dual GIP/GLP-1 receptor agonist reference compound. Third-party tested, COA available. In-vitro research use only.
COA-Backed Quality — if a delivered item is damaged, defective, or incorrect, contact us within 48 hours and we'll make it right per our Refund & Return Policy.
For Research Use Only. Not intended for human consumption, veterinary use, or any clinical application, sold exclusively for laboratory and in-vitro research. By purchasing, you confirm you are a qualified researcher.
Secure Checkout
VISAMastercardAMEXDiscover SSL Secured
Category
Peptides
Purity
High purity (research grade)
Storage
Refrigerate at 2–8°C
Form
Lyophilized powder
Shipping
Ships in 24–48 business hours · discreet
Overview
About Tirzepatide 10mg
Tirzepatide 10mg is a synthetic 39-amino-acid peptide supplied by Echo Peptides exclusively for laboratory, in-vitro research use. Sourced from qualified production channels, it is presented as a lyophilized reference compound for investigators studying dual incretin receptor pharmacology in controlled experimental settings.
As a reference agonist, tirzepatide engages both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence incorporates Aib (2-aminoisobutyric acid) substitutions and a C20 fatty diacid chain that promote conformational and metabolic stability, making it a useful comparator in cell-culture and preclinical models of incretin signaling.
Key research areas
Dual GIP and GLP-1 receptor agonism and multi-receptor signaling crosstalk
Incretin-mediated glucose homeostasis and insulin secretion mechanisms in vitro
Energy balance, satiety, and gastric emptying processes in preclinical models
Structure-activity relationships involving Aib residues and fatty-acid lipidation
Comparative studies of peptide stability and receptor binding kinetics
Solubility: Reconstitutes in bacteriostatic water or research buffers
Storage: Refrigerate at 2–8°C; long-term stability when lyophilized
Quality: Third-party tested for identity and purity; a Certificate of Analysis is available
This product is intended strictly for laboratory and in-vitro research use only. It is not for human or veterinary use, nor for any diagnostic or therapeutic application.
Regulatory notice. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease, and not for human or veterinary use. Sold exclusively for laboratory and in-vitro research by qualified professionals — always follow proper laboratory safety protocols.
This vial
Working with the 10mg vial
This vial contains 10 mg of lyophilized material. Reconstitution does not change that mass — it changes the volume it occupies — so the concentration you end up with is set entirely by how much diluent you add.
Diluent added
Concentration
Concentration
Molarity
1 mL
10 mg/mL
10000 µg/mL
2.08 mM
2 mL
5 mg/mL
5000 µg/mL
1.04 mM
3 mL
3.33 mg/mL
3333 µg/mL
0.692 mM
5 mL
2 mg/mL
2000 µg/mL
0.415 mM
Molarity uses this compound's verified molecular weight of 4813.5 g/mol.
Available sizes of Tirzepatide
Each strength is stocked and documented separately. Cost per mg is shown so the sizes can be compared directly.
Figures are unit conversions for handling reference material in vitro. Nothing here is a dose or a protocol.
Frequently Asked Questions
What makes tirzepatide a dual receptor agonist in research models?
Tirzepatide is a 39-amino-acid peptide engineered to bind both the GIP and GLP-1 receptors. Researchers use it as a reference compound to study how simultaneous engagement of these two incretin pathways affects signaling readouts in cell-culture and preclinical systems, compared with single-receptor agonists.
Why does the sequence include Aib residues and a C20 fatty diacid chain?
The 2-aminoisobutyric acid (Aib) substitutions and the C20 fatty diacid chain are structural modifications that enhance conformational and metabolic stability of the peptide in experimental settings. These features make tirzepatide a useful comparator for structure-activity and stability studies in vitro.
How should Tirzepatide 10mg be stored and reconstituted for laboratory work?
The lyophilized powder should be refrigerated at 2–8°C and offers long-term stability in its dry form. For research use it reconstitutes in bacteriostatic water or standard research buffers. Each batch is third-party tested for identity and purity, and a Certificate of Analysis is available.
